Top Markets
Coin of the day
Universal Vision Biotechnology Co., Ltd. Universal Vision Biotechnology Co., Ltd.

Universal Vision Biotechnology Co., Ltd.

3218
Κατάταξη σε μετοχές #14904
Universal Vision Biotechnology Co., Ltd., established in 1992 and based in... Universal Vision Biotechnology Co., Ltd., established in 1992 and based in Taipei, Taiwan, manages a network of eye care clinics across both Taiwan and China. The company delivers a comprehensive range of ophthalmic services, encompassing advanced surgical interventions and treatments for various ocular conditions. Its surgical specialties include laser vision correction for common refractive errors such as myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related vision decline). They also perform intraocular lens procedures for presbyopia and cataracts, employing advanced techniques like phacoemulsification and femtosecond laser surgery. Beyond surgical solutions, Universal Vision addresses a wide spectrum of eye health concerns, offering services for myopia control, dry eye syndrome, retinal detachment, macular degeneration, strabismus (crossed eyes), amblyopia (lazy eye), and numerous other ophthalmic ailments. The company further provides a diverse array of vision products and optical aids, including various eyeglass frames, specialized multifocal and progressive lenses for myopia and presbyopia, sunglasses, orthokeratology, rigid gas permeable lenses, and both conventional and colored contact lenses. Nutritional eye supplements are also available. Additional offerings include oculoplastic and micro cosmetic eye surgery, alongside bespoke aesthetic medicine consultations. Furthermore, Universal Vision engages in optometric services, hospital administration, technical advisory roles, and the distribution and rental of medical equipment.
Τιμή μετοχής
$4.55
Κεφαλαιοποίηση
$385.27M
Αλλαγή (1 ημέρα)
-0.35%
Αλλαγή (1 έτος)
-21.53%
Χώρα
TW
Εμπόριο Universal Vision Biotechnology Co., Ltd. (3218)

Κατηγορία

EPS για Universal Vision Biotechnology Co., Ltd. (3218)
EPS στις 2026 TTM: 0
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Universal Vision Biotechnology Co., Ltd., το τρέχον EPS της εταιρείας (TTM) είναι 0. Στο τέλος του 2026, η εταιρεία είχε EPS 0, ίσο με το EPS του 2026 που ήταν 0.
Ιστορικό EPS της Universal Vision Biotechnology Co., Ltd. από 2026 έως 2026
EPS στο τέλος κάθε έτους
Έτος EPS Αλλαγή
Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες.
EPS για παρόμοιες εταιρείες ή ανταγωνιστές